Navigation Links
MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
Date:6/23/2011

EX (MAP0004, Orally Inhaled DHE) in Healthy Volunteers — Results from 3 Clinical Studies: Pooled analyses assessing the clinical pharmacokinetics of LEVADEX and its primary metabolite across three recent clinical studies show consistent pharmacokinetic results and rapid absorption via the pulmonary route of administration.

Abstract #: A-345-0001-00616

Poster presentations will be available on the Publications section of MAP Pharmaceuticals' website at http://www.mappharma.com by the conclusion of the Congress.

About LEVADEX® LEVADEX is an investigational drug for migraine. The Company has submitted a New Drug Application to the U.S. Food and Drug Administration for the potential acute treatment of migraine in adults. In the clinical trial, patients administered LEVADEX themselves using the proprietary TEMPO® inhaler.  LEVADEX contains a novel formulation of dihydroergotamine (DHE).  LEVADEX was evaluated in the efficacy portion of FREEDOM-301, MAP Pharmaceuticals' Phase 3 pivotal trial, which included 395 patients in the LEVADEX arm and 397 patients in the placebo arm.  In the Phase 3 trial, patients taking LEVADEX had statistically significant improvement at two hours compared to patients on placebo for all four co-primary endpoints:

  • Pain relief: 58.7 percent of patients who received LEVADEX compared with 34.5 percent for placebo (p<0.0001);
  • Phonophobia free: 52.9 percent of patients who received LEVADEX compared with 33.8 percent for placebo (p<0.0001);
  • Photophobia free: 46.6 percent of patients who received LEVADEX compared with 27.2 percent for placebo (p<0.0001); and
  • Nausea free: 67.1 percent of patients who received LEVADEX compared with 58.7 percent for placebo (p=0.02).

  • The most common adverse event reported was medication aftertaste at six percent versus two percent for placebo.  The next most commo
    '/>"/>

    SOURCE MAP Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
    (Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
    (Date:8/27/2015)... 2015 According to a new market research ... Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, ... by MarketsandMarkets, the Medical Lifting Sling Market is poised to reach ... at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
    Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
    ... Inc. (NYSE: HGR ) announced preliminary net ... 30, 2010, an increase of $14.4 million, or 7.5%, ... diluted earnings per share, which excludes the cost of ... connection with the pending acquisition of Accelerated Care Plus ...
    ... NEW YORK, Oct. 18 Reportlinker.com announces that ... its catalogue: Global Veterinary Vaccines ... This report analyzes the worldwide markets ... following Product segments: Companion Animal Vaccines (Canine Vaccines, ...
    Cached Medicine Technology:Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings 2Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings 3Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings 4Reportlinker Adds Global Veterinary Vaccines Industry 2Reportlinker Adds Global Veterinary Vaccines Industry 3Reportlinker Adds Global Veterinary Vaccines Industry 4Reportlinker Adds Global Veterinary Vaccines Industry 5Reportlinker Adds Global Veterinary Vaccines Industry 6Reportlinker Adds Global Veterinary Vaccines Industry 7Reportlinker Adds Global Veterinary Vaccines Industry 8Reportlinker Adds Global Veterinary Vaccines Industry 9Reportlinker Adds Global Veterinary Vaccines Industry 10Reportlinker Adds Global Veterinary Vaccines Industry 11Reportlinker Adds Global Veterinary Vaccines Industry 12Reportlinker Adds Global Veterinary Vaccines Industry 13Reportlinker Adds Global Veterinary Vaccines Industry 14Reportlinker Adds Global Veterinary Vaccines Industry 15Reportlinker Adds Global Veterinary Vaccines Industry 16Reportlinker Adds Global Veterinary Vaccines Industry 17Reportlinker Adds Global Veterinary Vaccines Industry 18Reportlinker Adds Global Veterinary Vaccines Industry 19Reportlinker Adds Global Veterinary Vaccines Industry 20Reportlinker Adds Global Veterinary Vaccines Industry 21Reportlinker Adds Global Veterinary Vaccines Industry 22Reportlinker Adds Global Veterinary Vaccines Industry 23
    (Date:8/28/2015)... ... August 28, 2015 , ... Saint ... grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine in a ... for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... for documenting and diagramming network and data center assets and audio-video devices, recently ... Model, Cisco Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of ... Best Places to Work in Healthcare by Modern Healthcare and will be honored ... Now in its eighth year, the Best Places to Work in Healthcare program recognizes ...
    (Date:8/28/2015)... ... August 28, 2015 , ... CARF International ... adolescent residential, counseling, day treatment and intensive family based services. , By pursuing ... quality and its pursuit of excellence. As a nonprofit charity for more than ...
    (Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... increased patient loyalty at a low cost. Personalized with practice contact information and ... existing patients. Dental offices can also incorporate Calendars into seasonal mailings, thank you ...
    Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
    ... to feature Mayo Clinic ... ... ulcerative,colitis patients, caregivers, and healthcare professionals can now register,for "Inflammatory Bowel ... through the Crohn,s & Colitis,Foundation will take place on Thursday, March ...
    ... Jan. 29 The Board of,Directors of BD (Becton, ... a,quarterly dividend of 28.5 cents per common share. The ... of record on March 10, 2008. The,indicated annual dividend ... BD, a leading global medical technology company that manufactures ...
    ... with NBME and Announces ... Program, TAMPA, Fla., Jan. 29 The ... Inc. (ABQAURP) is pleased to,announce the organization has ... Examiners(R) (NBME(SM)) to oversee and administer ABQAURP,s,professional certification ...
    ... Disorders and Stroke has awarded $1.7 million to University of ... Americans $50 billion a yearlow back pain. , Back pain ... 45 years old and is experienced by 50 to 80 ... pain becomes chronic if it persists for more than three ...
    ... Stephen J. Ubl,president and CEO of AdvaMed, issued ... Commerce Oversight and Investigations,Subcommittee hearing on the recent ... at Risk: FDA,s Self-Assessment":, "The Food and ... bearer for safety, but critical steps must be ...
    ... Arcadian Health Plan, Inc., a,leading provider of ... its benefits for 2008 and expanded into the,state ... successful rollouts in,Oklahoma, Georgia, South Carolina and Maine., ... premiums, free annual,physicals and flu shots, dental benefits, ...
    Cached Medicine News:Health News:Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 3Health News:UC scientists awarded $1.7 million for low back pain research 2Health News:AdvaMed Supports Increased Funding for FDA 2Health News:Bright Options for Medicare Beneficiaries in Louisiana 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: